Glutaminsyre-decarboxylase-antistoffer og diabetes.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Glutaminsyre-decarboxylase-antistoffer og diabetes. / Mandrup-Poulsen, Thomas.

I: Ugeskrift for læger, Bind 169, Nr. 4, 2007, s. 300-4.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Mandrup-Poulsen, T 2007, 'Glutaminsyre-decarboxylase-antistoffer og diabetes.', Ugeskrift for læger, bind 169, nr. 4, s. 300-4.

APA

Mandrup-Poulsen, T. (2007). Glutaminsyre-decarboxylase-antistoffer og diabetes. Ugeskrift for læger, 169(4), 300-4.

Vancouver

Mandrup-Poulsen T. Glutaminsyre-decarboxylase-antistoffer og diabetes. Ugeskrift for læger. 2007;169(4):300-4.

Author

Mandrup-Poulsen, Thomas. / Glutaminsyre-decarboxylase-antistoffer og diabetes. I: Ugeskrift for læger. 2007 ; Bind 169, Nr. 4. s. 300-4.

Bibtex

@article{14226150acd211ddb538000ea68e967b,
title = "Glutaminsyre-decarboxylase-antistoffer og diabetes.",
abstract = "The 1999 WHO classification delineates immune mediated type 1 diabetes from other types of diabetes by the presence of auto-antibodies against beta-cell constituents. The GAD65 auto-antibody test is the method of first choice because it has the highest sensitivity, specificity and positive predictive value and is the most standardized and well-characterized type 1 diabetes related auto-antibody analysis. It is recommended that demonstration of GAD auto-antibodies leads to diagnosis, classification or re-classification of diabetes patients as immune mediated type 1 diabetes. Udgivelsesdato: 2007-Jan-22",
author = "Thomas Mandrup-Poulsen",
note = "Keywords: Autoantibodies; Autoantigens; Decision Making; Diabetes Mellitus, Type 1; Glutamate Decarboxylase; Humans; Insulin-Secreting Cells; Predictive Value of Tests; Risk Factors; Sensitivity and Specificity",
year = "2007",
language = "Dansk",
volume = "169",
pages = "300--4",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "4",

}

RIS

TY - JOUR

T1 - Glutaminsyre-decarboxylase-antistoffer og diabetes.

AU - Mandrup-Poulsen, Thomas

N1 - Keywords: Autoantibodies; Autoantigens; Decision Making; Diabetes Mellitus, Type 1; Glutamate Decarboxylase; Humans; Insulin-Secreting Cells; Predictive Value of Tests; Risk Factors; Sensitivity and Specificity

PY - 2007

Y1 - 2007

N2 - The 1999 WHO classification delineates immune mediated type 1 diabetes from other types of diabetes by the presence of auto-antibodies against beta-cell constituents. The GAD65 auto-antibody test is the method of first choice because it has the highest sensitivity, specificity and positive predictive value and is the most standardized and well-characterized type 1 diabetes related auto-antibody analysis. It is recommended that demonstration of GAD auto-antibodies leads to diagnosis, classification or re-classification of diabetes patients as immune mediated type 1 diabetes. Udgivelsesdato: 2007-Jan-22

AB - The 1999 WHO classification delineates immune mediated type 1 diabetes from other types of diabetes by the presence of auto-antibodies against beta-cell constituents. The GAD65 auto-antibody test is the method of first choice because it has the highest sensitivity, specificity and positive predictive value and is the most standardized and well-characterized type 1 diabetes related auto-antibody analysis. It is recommended that demonstration of GAD auto-antibodies leads to diagnosis, classification or re-classification of diabetes patients as immune mediated type 1 diabetes. Udgivelsesdato: 2007-Jan-22

M3 - Tidsskriftartikel

C2 - 17274923

VL - 169

SP - 300

EP - 304

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 4

ER -

ID: 8465646